[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n HJDTxOqujwXgxAVNa/opa8a8+3IzN7D0M3CZPfNmFtNuAnpIwjopwkZid3DqJdXz\n KTSfyKCmC8yYDFvXr9iszw==\n\n', u'0001104659-04-028713.txt : 20040928\n', u'0001104659-04-028713.hdr.sgml : 20040928\n', u'20040928124238\nACCESSION NUMBER:\t\t0001104659-04-028713\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t8\nCONFORMED PERIOD OF REPORT:\t20040927\nITEM INFORMATION:\t\tEntry into a Material Definitive Agreement\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nITEM INFORMATION:\t\tOther Events\nITEM INFORMATION:\t\tFinancial Statements and Exhibits\nFILED AS OF DATE:\t\t20040928\nDATE AS OF CHANGE:\t\t20040928\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tDJ ORTHOPEDICS INC\n\t\tCENTRAL INDEX KEY:\t\t\t0001157972\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]\n\t\tIRS NUMBER:\t\t\t\t330978270\n\t\tSTATE OF INCORPORATION:\t\t\tDE\n\t\tFISCAL YEAR END:\t\t\t1231\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-16757\n\t\tFILM NUMBER:\t\t041049095\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t2985 SCOTT STREET\n\t\tCITY:\t\t\tVISTA\n\t\tSTATE:\t\t\tCA\n\t\tZIP:\t\t\t92083\n\t\tBUSINESS PHONE:\t\t7607271280\n', u'\n', u'\n', u'8-K\n', u'1\n', u'a04-10980_18k.htm\n', u'8-K\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'UNITED\nSTATES', u'\n', u'SECURITIES\nAND EXCHANGE COMMISSION', u'\n', u'WASHINGTON, D.C. 20549', u'\n', u'\xa0', u'\n', u'FORM\n8-K', u'\n', u'\xa0', u'\n', u'CURRENT\nREPORT', u'\n', u'\xa0', u'\n', u'PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES', u'\nEXCHANGE ACT OF 1934', u'\n', u'\xa0', u'\n', u'SEPTEMBER\n27, 2004', u'\n', u'Date\nof Report (Date of earliest event reported)', u'\n', u'\xa0', u'\n', u'DJ\nORTHOPEDICS, INC.', u'\n', u'(Exact name of\nRegistrant as specified in its charter)', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Delaware', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'001-16757', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'33-0978270', u'\n', u'\n', u'\n', u'\n', u'\n', u'(State or other\n  jurisdiction of', u'\n  incorporation)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(Commission File\n  Number)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(I.R.S. Employer\n  Identification', u'\n  Number)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'2985 Scott Street', u'\n', u'Vista, California', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'92083', u'\n', u'\n', u'\n', u'\n', u'\n', u'(Address of principal\n  executive offices)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(Zip Code)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'(800) 336-5690', u'\n', u'Registrant\x92s telephone\nnumber, including area code', u'\n', u'\xa0', u'\n', u'N/A', u'\n', u'(Former name or former\naddress, if changed since last report)', u'\n', u'\xa0', u'\n', u'Check the appropriate box\nbelow if the Form 8-K filing is intended to simultaneously satisfy the filing\nobligation of the registrant under any of the following provisions (see General\nInstruction A.2. below):', u'\n', u'\xa0', u'\n', u'o', u'\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR\n230.425)', u'\n', u'o', u'\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR\n240.14a-12)', u'\n', u'o', u'\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange\nAct (17 CFR 240.14d-2(b))', u'\n', u'o', u'\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange\nAct (17 CFR 240.13e-4(c))', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\jkeene\\04-10980-1\\task190013\\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'Item 1.01.\xa0 Entry into a Material Definitive Agreement.', u'\n', u'\xa0', u'\n', u"On September 28, 2004, dj Orthopedics, Inc.'s\nsubsidiary, dj Orthopedics LLC, completed the acquisition of KD Innovation A/S,\none of the Company\x92s third party distributors in Scandinavia.\xa0 In the transaction, which has an effective\ndate as of August 30, 2004, dj Orthopedics acquired all of the outstanding\nstock of the former distributor for a cash payment of $700,000 and an\nadditional amount up to $500,000 payable over a period of years if financial\ngoals are met.\xa0 The acquired company,\nrenamed dj Orthopedics Nordic ApS, is headquartered in H", u'&qout;', u'rsholm, near Copenhagen, Denmark and has\ndirect responsibility for sales, marketing and distribution of dj Orthopedics\x92\nproducts in Denmark, Finland, Norway and Sweden.\xa0 A copy of the stock purchase agreement and a\npress release announcing the transaction are filed as Exhibit 10.1 and 99.1,\nrespectively, to this Current Report.', u'\n', u'\xa0', u'\n', u'Item 2.02.\xa0 Results of Operations and Financial\nCondition.', u'\n', u'\xa0', u'\n', u'On September 28, 2004, dj Orthopedics, Inc., issued a press release\nannouncing an update on its expected third quarter financial results and the\nintegration of its Regentek division.\xa0 A\ncopy of the press release is furnished as Exhibit 99.2 to this Current Report.', u'\n', u'\xa0', u'\n', u'Item 8.01.\xa0 Other Events.', u'\n', u'\xa0', u'\n', u'On September 28, 2004, dj Orthopedics, Inc., issued a press release\nannouncing that on September 27, 2004, its board of directors authorized a\nprogram to repurchase stock.\xa0 A copy of\nthe press release containing further details of the program is filed as Exhibit\n99.3 to this Current Report.', u'\n', u'\xa0', u'\n', u'Item 9.01. Financial Statements and\nExhibits.', u'\n', u'\xa0', u'\n', u'(c)', u'\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Exhibits.', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'Exhibit No.', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Document', u'\n', u'\n', u'\n', u'\n', u'\n', u'10.1', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Stock purchase agreement between dj Orthopedics, LLC\n  and KD Holdings dated as of August 30, 2004.', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.1', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Press release dated September 28, 2004 relating to\n  dj Orthopedics, Inc.\x92s acquisition of KD Innovation A/S.', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.2', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Press release dated September 28, 2004 relating to\n  dj Orthopedics, Inc.\x92s expected third quarter financial results and Regentek\n  integration.', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.3', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Press release dated September 28, 2004 relating to\n  dj Orthopedics, Inc.\x92s stock repurchase program.', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'2', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='2',FILE='C:\\JMS\\jkeene\\04-10980-1\\task190013\\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'SIGNATURES', u'\n', u'\xa0', u'\n', u'Pursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has\nduly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'DJ ORTHOPEDICS, INC.', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'(Registrant)', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Date:', u'\n', u'\n', u'\n', u'September 27, 2004', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'BY:', u'\n', u'\n', u'\n', u'/s/\n  VICKIE L. CAPPS', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Vickie\n  L. Capps', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Senior\n  Vice President, Finance and Chief Financial Officer', u'\n  (Principal Financial Officer)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'3', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='3',FILE='C:\\JMS\\jkeene\\04-10980-1\\task190013\\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' ", u'\n', u'\n', u'\n', u'\n', u'EX-10.1\n', u'2\n', u'a04-10980_1ex10d1.htm\n', u'EX-10.1\n', u'\n', u'\n', u'Exhibit\n10.1', u'\n', u'\xa0', u'\n', u'STOCK\nPURCHASE AGREEMENT', u'\n', u'\xa0', u'\n', u'This Stock\nPurchase Agreement (the \x93Agreement\x94) is entered into as of August 30, 2004 (the\n\x93Effective Date\x94), by and between KD Holdings, a Denmark corporation\n(\x93Holdings\x94), Kirsten Damgaard, an individual and the sole shareholder of\nHoldings (\x93Stockholder\x94) (Holdings and Stockholder are hereinafter collectively\nreferred to as \x93Seller\x94), and dj Orthopedics, LLC, a Delaware limited liability\ncompany (\x93Buyer\x94).', u'\n', u'\xa0', u'\n', u'R', u' ', u'E', u'\n', u'C', u' ', u'I', u' ', u'T', u' ', u'A', u' ', u'L', u' ', u'S', u'\n', u'\xa0', u'\n', u'WHEREAS, Buyer and\nSeller have entered into that certain letter agreement dated September 29, 2003\n(the \x93Option\x94) pursuant to which Seller granted Buyer the option to purchase,\nupon terms and conditions set forth therein, all of the outstanding capital\nstock in dj Orthopedics Nordic ApS, formerly KD Innovations, (hereinafter, the\n\x93Acquired Business\x94); and', u'\n', u'\xa0', u'\n', u'WHEREAS, Buyer\nwishes to exercise such Option and purchase the capital stock of the Acquired\nBusiness, and Seller wishes to sell such capital stock, all on the terms and\nconditions set forth in this Agreement.', u'\n', u'\xa0', u'\n', u'A', u' ', u'G', u'\n', u'R', u' ', u'E', u' ', u'E', u' ', u'M', u' ', u'E', u' ', u'N', u' ', u'T', u'\n', u'\xa0', u'\n', u'NOW, THEREFORE, in consideration of the mutual\nrepresentations, warranties, covenants and agreements contained herein, the\nreceipt and sufficiency of which are hereby acknowledged, the parties hereto\nagree as follows:', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'ARTICLE 1', u'\n', u'\xa0', u'\n', u'PURCHASE AND SALE OF\nSTOCK', u'\n', u'\xa0', u'\n', u'1.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Purchase and Sale of Stock', u'.\xa0 Subject to the terms and conditions of this\nAgreement and pursuant to the exercise of the Option, Seller does hereby sell,\ntransfer, convey, assign and deliver to Buyer, and Buyer does hereby purchase,\nacquire and accept from Seller, all of Seller\x92s right, title and interest in\nand to the outstanding shares of capital stock of the Acquired Business (the\n\x93Stock\x94).', u'\n', u'\xa0', u'\n', u'1.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Transactions on the Effective Date', u'.\xa0\xa0 In consideration for the sale, assignment,\ntransfer and delivery of the Stock, Buyer shall pay Holdings in readily\navailable funds on the Effective Date pursuant to wire transfer instructions\nprovided by Seller to Buyer the sum of $700,000 in U.S. dollars (unless\nspecifically indicated to the contrary, all sums set forth in this Agreement\nshall be in U.S. dollar currency).\xa0\nHoldings shall deliver to Buyer on the Effective Date the certificates\nor other evidence of the Stock, accompanied by such transfer documents as are\nnecessary under the laws of Denmark to transfer such Stock to Buyer and to\nevidence Buyer as the holder of all right, title and interest in the Stock.', u'\n', u'\xa0', u'\n', u'1', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='1',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'1.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Additional Scheduled Payments', u'.\xa0 As additional consideration, Buyer hereby\nagrees to pay Holdings the following amounts subject to the following\nconditions:', u'\n', u'\xa0', u'\n', u'(a)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Buyer shall make an additional\npayment to Holdings on September 1, 2005 in the amount of $125,000 if the\naggregate \x93net operating income\x94 (as defined below) of the Acquired Business in\nthe country of Denmark during calendar 2004 and the six-month period ending\nJune 30, 2005 equals or exceeds the sum of $250,000, and if such net operating\nincome for the country of Denmark during such period is less than $250,000, then\nsuch payment shall be reduced in proportion to the shortfall in such net\noperating income.', u'\n', u'\xa0', u'\n', u'(b)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Similarly, Buyer shall make an\nadditional payment to Holdings on September 1, 2006 in the amount of $125,000\nif the aggregate \x93net operating income\x94 (as defined below) of the Acquired\nBusiness in the country of Denmark during calendar 2005 and the six-month\nperiod ending June 30, 2006 equals or exceeds the sum of $360,000, and if such\nnet operating income for the country of Denmark during such period is less than\n$360,000, then such payment shall be reduced in proportion to the shortfall in\nsuch net operating.', u'\n', u'\xa0', u'\n', u'1.4\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Possible Additional Consideration', u'.\xa0 Buyer hereby agrees to pay Holdings\nadditional consideration of up to $250,000, at the time and in the manner described\nbelow, if the Acquired Business achieves some or all the following cumulative\nnet operating income goals as of December 31 of the years shown below:', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'2005', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'258,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'2006', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'687,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'2007', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'1,303,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'2008', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'$', u'\n', u'\n', u'\n', u'2,065,000', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'On March 1, 2006 and each subsequent March 1 through March 1, 2009, the\ncumulative net operating income of the Acquired Business shall be determined as\nof the preceding December 31, and if the applicable goal has been exceeded,\nBuyer shall pay Holdings as additional consideration hereunder an amount equal\nto 50% of such excess.\xa0 Once the\ncumulative total of such additional consideration reaches $250,000, no further\nsuch payments will be made.\xa0 The failure\nof the Acquired Business to reach any applicable goal in a year subsequent to a\nyear in which the applicable goal was achieved will not affect any of such\nadditional consideration previously paid for the year in which such applicable\ngoal was achieved.', u'\n', u'\xa0', u'\n', u'1.5\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Determination\nof Net Operating Income', u'.\xa0\xa0 For\npurposes of sections 1.3 and 1.4 above, \x93net operating income\x94 shall be\ndetermined by calculating the gross profit of the Acquired Business and\nsubtracting therefrom selling expenses, marketing expenses, general and\nadministrative expenses and depreciation.\xa0\nIn addition, the net operating income figures in sections 1.3 and 1.4\nabove have been calculated using an exchange rate of 6.5 DKK per US dollar, and\nsuch exchange rate shall be used for purposes of all calculations under\nsections 1.3 and 1.4 above.\xa0 The\ndetermination of such net operating income for the Acquired Business shall be\nmade by Buyer.\xa0 Following June 30 of\n2005 and 2006, Buyer shall, to determine the payment under section 1.3 above,\ncalculate and report the net', u'\n', u'\xa0', u'\n', u'2', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='2',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'operating income of the Acquired Business in the country of Denmark for\nthe period required by section 1.3, limiting such calculation for this purpose\nto sales achieved in Denmark and expenses incurred in Denmark.\xa0 Following December 31 of each year from 2005\nto and including 2008, Buyer shall, to determine the payment under section 1.4\nabove, calculate and report the cumulative net operating income of the Acquired\nBusiness as a whole from January 1, 2005 through each such December 31.\xa0 Buyer shall report to Seller each such\ncalculation, which shall be the basis for any payment of additional\nconsideration by Buyer under either section 1.3 or 1.4 above.\xa0 If Seller disagrees with the determination\nof Buyer, the parties agree to meet and discuss any such disagreement in order\nto resolve any differences.\xa0 If the\ndisagreement is not resolved to Seller\x92s satisfaction, Seller shall be entitled\nto resolve such disagreement through the dispute resolution procedure in\nsection 5.4(b) below.', u'\n', u'\xa0', u'\n', u'1.6\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Continued Employment of Stockholder', u'.\xa0 Stockholder understands that her continued\nemployment and active participation in the Acquired Business during the period\nof time reflected in section 1.4 above is a material consideration to the\nSeller\x92s participation in the transaction provided for in this Agreement.\xa0 Accordingly, if Stockholder voluntarily\nterminates her employment with the Acquired Business prior to the completion of\nthe payment opportunity under section 1.4 above, then Buyer shall have no\nfurther obligation to make any payments under such section.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'ARTICLE 2', u'\n', u'\xa0', u'\n', u'REPRESENTATIONS AND\nWARRANTIES', u'\nOF THE SELLER', u'\n', u'\xa0', u'\n', u'Each of Holdings and the Stockholder represents and warrants, jointly\nand severally, to the Buyer as follows:', u'\n', u'\xa0', u'\n', u'2.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Organization\nand Good Standing', u'.\xa0 The Acquired\nBusiness is a corporation duly organized, validly existing and in good standing\nunder the laws of Denmark.\xa0 The Acquired\nBusiness is duly qualified and registered to transact business and is in good\nstanding in every country and other jurisdiction in which the character and\nextent of its business makes such qualification or registration necessary.\xa0 The Acquired Business has all necessary\ncorporate power and authority, including all necessary licenses and permits, to\ncarry on its business as it is now being conducted, and to own or lease and\noperate its properties and assets.', u'\n', u'\xa0', u'\n', u'2.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Authorization\nand Approvals', u'.\xa0 Holdings has all\nrequisite corporate power and authority to enter into this Agreement and to\nperform its obligations hereunder.\xa0 This\nAgreement has been duly executed and delivered by the Seller and constitutes\nthe legal, valid and binding obligation of Seller, enforceable in accordance\nwith its terms, except as may be limited by bankruptcy, reorganization,\ninsolvency, moratorium or other laws relating to or affecting the enforcement\nof creditors\x92 rights and remedies generally.\xa0\nThis Agreement has been duly and validly authorized by and approved by\nall requisite corporate action on the part of Holdings\x92 Board of Directors and', u'\n', u'\xa0', u'\n', u'3', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='3',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'stockholders.\xa0 No further\napprovals or consents by, or filings with, any national, regional or other\ncourt or governmental or administrative body, agency or other third party is\nrequired in connection with the execution and delivery by the Seller of this\nAgreement, or the consummation by the Seller of the transactions contemplated\nhereby.', u'\n', u'\xa0', u'\n', u'2.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Equity Structure of the Acquired\nBusiness', u'.\xa0 The Stock represents all\nof the issued and outstanding capital stock of the Acquired Business and no\nother stock or equity interest in the Acquired Business has been issued or is\noutstanding.\xa0 Except for the Option and\nthis Agreement, there are no options, warrants, convertible debt or securities,\ncalls, agreements, arrangements or understandings or other rights of any kind\nor character to purchase any equity interest in the Acquired Business or that\nwould otherwise result in the ownership of any equity interest in the Acquired\nBusiness by any party other than the ownership of the Stock by Holdings.\xa0 The equity interest represented by the\nStock, and the Stock itself, has been duly authorized by all necessary\ncorporate action of the Acquired Business, is validly issued, fully paid and\nnonassessable and has been issued in full compliance with all applicable laws\nand regulations.', u'\n', u'\xa0', u'\n', u'2.4\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Title to Stock', u'.\xa0 Holdings is the registered and beneficial\nowner of the Stock, free and clear of any liens, encumbrances, security\ninterests, restrictions or claims whatsoever, with full power and authority to\nconvey the Stock to Buyer in accordance with the terms of this Agreement.\xa0 No other person or party has or can claim\nany interest of any kind in the Stock or in any right in respect of the Stock.', u'\n', u'\xa0', u'\n', u'2.5\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'No\nConflicts', u'.\xa0 Neither the execution\nand delivery of this Agreement nor the consummation of the transactions\ncontemplated hereby will (a) violate any provision of the charter or\norganizational documents of the Acquired Business or Holdings, (b) violate, or\nbe in conflict with, or constitute a default (or other event which, with the\ngiving of notice or lapse of time or both, would constitute a default) under,\nor give rise to any right of termination, cancellation or acceleration under\nany of the terms, conditions or provisions of any lease, license, promissory\nnote, contract, agreement, mortgage, deed of trust or other instrument or\ndocument to which the Acquired Business or the Seller is a party or by which\nthe Acquired Business or the Seller or any of its or her respective\xa0 properties or assets may be bound, (c)\nviolate any order, writ, injunction, decree, law, statute, rule\xa0or\nregulation of any court or governmental authority applicable to the Acquired\nBusiness or the Seller or any of its or her respective properties or assets or\n(d) give rise to a declaration or imposition of any claim, lien, charge,\nsecurity interest or encumbrance of any nature whatsoever upon any of the\nassets of the Acquired Business.', u'\n', u'\xa0', u'\n', u'2.6\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Taxes', u'.\xa0 The Acquired Business has paid or caused to\nbe paid within the time and in the manner prescribed by law all national, regional\nand local taxes of any type, including without limitation, income, franchise,\ngross receipts, sales or property taxes, payable or due from and owed by the\nAcquired Business for all periods ending on or prior to the date hereof except\nfor taxes which are accrued but not yet due and payable.\xa0 The Acquired Business has collected all\nsales, use and value added taxes required to be collected, and has remitted, or\nwill remit on a timely basis, such amounts to the appropriate governmental\nauthorities and has furnished properly completed exemption certificates for all\nexempt transactions.\xa0 The Acquired\nBusiness has properly withheld income or similar taxes and required social\ncharges and paid such amounts to the proper', u'\n', u'\xa0', u'\n', u'4', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='4',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'governmental authority with respect to all employees of the Acquired\nBusiness.\xa0 None of the assets of the\nAcquired Business are subject to any liens in respect of taxes (other than for\ncurrent taxes not yet due and payable).', u'\n', u'\xa0', u'\n', u'2.7\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Contracts', u'.\xa0 Schedule 2.7 hereto contains a complete,\ncurrent and correct list of all material contracts, commitments, obligations or\nagreements of the Acquired Business, whether written or oral, formal or\ninformal (the \x93Contracts\x94).\xa0 To the\nknowledge of the Seller, no event has occurred which would constitute a default\n(or any event which, with the giving of notice or lapse of time or both, would\nconstitute a default) under any term or provision of any of the Contracts and\nthereby allow a party thereto to terminate or claim damages therefor.\xa0 Each of the Contracts is in full force and\neffect and is the legal, valid and binding obligation of the Acquired Business\nand, to the knowledge of the Seller, of the other parties thereto, enforceable\nin accordance with its terms, except as may be limited by bankruptcy,\nreorganization, insolvency, moratorium or other laws relating to or affecting\nthe enforcement of creditors\x92 rights and remedies generally.\xa0 The Acquired Business is not a party to any\nContract that restricts Acquired Business, or will restrict Buyer after the\nEffective Date, from carrying on the Acquired Business or any part thereof, or\nfrom competing in any line of business with any person, corporation or entity.', u'\n', u'\xa0', u'\n', u'2.8\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Title\nto Assets', u'.\xa0 The Acquired Business\nhas good, valid and marketable title to all of its assets.\xa0 All such assets are free and clear of title\ndefects, liens, claims, charges, pledges, security interests, easements or\nother encumbrances of any kind or nature whatsoever, except for liens, taxes\nand assessments not yet due and liens arising by law or in the ordinary course\nof business that do not materially adversely affect such assets or the\noperation of the Acquired Business.', u'\n', u'\xa0', u'\n', u'2.9\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Financial Statements', u'. Schedule\n2.9 contains the balance sheet of the Acquired Business as of August 28, 2004\n(the \x93Balance Sheet\x94) and the statement of income and expenses of the Acquired\nBusiness for the period from January 1, 2004 to the date of the Balance Sheet\n(the \x93Income Statement\x94 and collectively with the Balance Sheet, the \x93Financial\nStatements\x94).\xa0 The Financial Statements\n(i)\xa0have been prepared in conformity with generally accepted accounting\nprinciples applicable to companies in the countries is which the Acquired\nBusiness operates consistently applied with prior periods, and (ii) fairly\npresent the financial condition and results of operations of the Acquired\nBusiness as of the dates and for the periods indicated therein. The Balance\nSheet accurately reflects all liabilities, obligations and commitments of any\nnature (whether absolute, accrued, contingent or otherwise and whether matured\nor unmatured) of the Acquired Business except (a) liabilities, obligations or\ncommitments incurred since the date of the Balance Sheet in the ordinary course\nof business and consistent with past practice, (b) liabilities or obligations\ndescribed on Schedule 2.9 or Schedule 2.12 hereto and (c) other liabilities or\nobligations that are not material, individually or in the aggregate, to the\nAcquired Business.', u'\n', u'\xa0', u'\n', u'2.10\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Accounts\nReceivable', u'.\xa0 The Accounts Receivable\nshown in the Balance Sheet, subject to changes in the ordinary course of\nbusiness from the date of the Balance Sheet to the Effective Date, constitute\nall of the accounts receivable of the Acquired Business and represent ', u'bona', u'\n', u'fide', u' sales actually made or on or prior to such date in the ordinary\ncourse of business of the Acquired Business and consistent with past\npractices.\xa0 To Seller\x92s knowledge, there\nis no contest, claim or right of', u'\n', u'\xa0', u'\n', u'5', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='5',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'set-off contained in any oral or written agreement with any account\ndebtor relating to the amount or validity of any such Account Receivable.\xa0 The Accounts Receivable are valid and\ncollectible in the ordinary course of business.', u'\n', u'\xa0', u'\n', u'2.11\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Compliance\nWith Laws', u'.\xa0 To the knowledge of\nSeller, Seller has conducted the Acquired Business in compliance with, and is\nnot in violation of, applicable laws, statutes, ordinances, rules, regulations,\norders and other requirements of all national governmental authorities, and of all\nterritories, states, municipalities and other political subdivisions and\nagencies thereof, having jurisdiction over the Acquired Business, including\nwithout limitation all such laws, regulations, ordinances and requirements\nrelating to environment, antitrust, consumer protection, labor and employment,\nzoning and land use, immigration, health, and occupational safety,\xa0 except where the failure to be in compliance\nwould not have a material adverse effect on the Acquired Business.\xa0 The Acquired Business has not received any\nwritten notification of any asserted present or past failure to comply with any\nlaws, statutes, ordinances, rules, regulations, orders or other legal or\nregulatory requirements.', u'\n', u'\xa0', u'\n', u'2.12\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Litigation', u'.', u'\n', u'\xa0', u'\n', u'(a)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 Except\nas set forth on Schedule 2.12, there is no pending or, to the best knowledge of\nthe Seller, threatened action, suit, arbitration proceeding, investigation or\ninquiry before any court or governmental or administrative body or agency, or\nany private arbitration tribunal, against, relating to or affecting the\nAcquired Business, or the transactions contemplated by this Agreement, nor to\nthe best knowledge of the Seller, are there any facts or circumstances which\ncould reasonably lead to or provide the basis for any such threatened action, suit,\narbitration proceeding, investigation or inquiry.', u'\n', u'\xa0', u'\n', u'(b)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 There\nis not in effect any order, judgment or decree of any court or governmental or\nadministrative body or agency enjoining, barring, suspending, prohibiting or\notherwise limiting the Acquired Business or any officer, director or employee\nof the Acquired Business from conducting or engaging in any aspect of the\nAcquired Business, or requiring Seller or any officer, director or employee of\nSeller to take certain action with respect to any aspect of the Acquired\nBusiness.', u'\n', u'\xa0', u'\n', u'(c)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 The\nAcquired Business is not in violation of or in default under any order,\njudgment, writ, injunction or decree of any court or governmental or\nadministrative body or agency.', u'\n', u'\xa0', u'\n', u'2.13\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Brokers\nand Finders', u'.\xa0 Seller has not engaged\nor authorized any broker, finder, investment banker or other third party to act\non its behalf, directly or indirectly, as a broker, finder, investment banker\nor in any other like capacity in connection with this Agreement or the\ntransactions contemplated hereby, nor has Seller consented to or acquiesced in\nanyone so acting.\xa0 Seller knows of no\nclaim for compensation from any such broker, finder, investment banker or other\nthird party for so acting on behalf of Seller or any basis for such a claim.', u'\n', u'\xa0', u'\n', u'6', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='6',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'2.14\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Absence of Certain Changes', u'.\xa0 ', u'\xa0Since the date of the Balance Sheet, the\nAcquired Business has been conducted in the ordinary course consistent with\npast practice and, to the knowledge of Seller, there has not been:', u'\n', u'\xa0', u'\n', u'(a)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any event, occurrence or development\nof a state of circumstances or facts relating to the Acquired Business which,\nindividually or in the aggregate, has had or could reasonably be expected to\nhave a material adverse effect thereon;', u'\n', u'\xa0', u'\n', u'(b)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any sale, lease, license or other\ndisposition of any assets or properties of the Acquired Business, other than in\nthe ordinary course of business consistent with past practices;', u'\n', u'\xa0', u'\n', u'(c)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any creation or assumption by the\nAcquired Business of any lien, encumbrance or other charge on any of the assets\nor properties of the Acquired Business;', u'\n', u'\xa0', u'\n', u'(d)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any indebtedness for borrowed money\nincurred by the Acquired Business or any commitment to incur indebtedness for\nborrowed money entered into by the Acquired Business;', u'\n', u'\xa0', u'\n', u'(e)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 the incurrence by the Acquired\nBusiness of any material liability or obligation not in the ordinary course of\nbusiness and consistent with past practice;', u'\n', u'\xa0', u'\n', u'(f)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 the entering into a material\ncontract or any amendment, modification or termination of any Contract listed\non Schedule 2.7 other that the expiration of any such Contract by its terms;', u'\n', u'\xa0', u'\n', u'(g)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 the addition or loss of any employee\nof the Acquired Business, or any material increase in, or commitment to\nincrease, the direct or indirect compensation payable or to become payable to\nany employee of the Acquired Business, or the commitment to make severance,\nbonus or special payments to any such employee;', u'\n', u'\xa0', u'\n', u'(h)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any material condemnation, seizure,\ndamage, destruction or other casualty loss (whether or not covered by insurance)\naffecting any of the assets or properties of the Acquired Business; or', u'\n', u'\xa0', u'\n', u'(i)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 any notice of default or any other\nclaim, allegation or other assertion that the Acquired Business has been or\nwill be in breach or violation of any provision of any contract, agreement or\ninstrument to which it is a party and by which its assets are bound.', u'\n', u'\xa0', u'\n', u'ARTICLE 3', u'\n', u'\xa0', u'\n', u'REPRESENTATIONS AND\nWARRANTIES', u'\nOF BUYER', u'\n', u'\xa0', u'\n', u'Buyer represents\nand warrants to the Seller as follows:', u'\n', u'\xa0', u'\n', u'7', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='7',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'3.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Organization\nand Power', u'.\xa0 Buyer is a limited\nliability company duly organized, validly existing and in good standing under\nthe laws of the State of Delaware, and has all requisite corporate power and\nauthority to own, lease and operate its properties, and to carry on its\nbusiness, as such is now being conducted.', u'\n', u'\xa0', u'\n', u'3.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Authorization\nand Enforceability of Agreements', u'.\xa0\nBuyer has all requisite corporate power and authority to enter into this\nAgreement and to perform its obligations hereunder.\xa0 This Agreement has been duly executed and delivered by Buyer and\nconstitutes the legal, valid and binding obligation of Buyer, enforceable in\naccordance with its terms, except as may be limited by bankruptcy,\nreorganization, insolvency, moratorium or other laws relating to or affecting\nthe enforcement of creditors\x92 rights and remedies generally.\xa0 This Agreement been duly and validly\nauthorized by and approved by all requisite corporate action on the part of\nBuyer.\xa0 No further approvals or consents\nby, or filings with, any federal, state, municipal, foreign or other court or\ngovernmental or administrative body, agency or other third party is required in\nconnection with the execution and delivery by Buyer of this Agreement or the\nconsummation by Buyer of the transactions contemplated hereby.', u'\n', u'\xa0', u'\n', u'3.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'No\nConflicts', u'.\xa0 Neither the execution\nand delivery of this Agreement, nor the consummation of the transactions\ncontemplated hereby will (a) violate any provisions of the charter or Bylaws of\nBuyer, (b) violate, or be in conflict with, or constitute a default (or other\nevent which, with the giving of notice or lapse of time or both, would\nconstitute a default) under, or give rise to any right of termination,\ncancellation or acceleration under any of the terms, conditions or provisions\nof any material lease, license, promissory note, contract, agreement, mortgage,\ndeed of trust or other instrument or document to which Buyer is a party or by\nwhich Buyer or any of its properties or assets may be bound, (c) violate any\norder, writ, injunction, decree, law, statute, rule or regulation of any court\nor governmental authority applicable to Buyer or any of its properties or\nassets or (d) give rise to a declaration or imposition of any claim, lien,\ncharge, security interest or encumbrance of any nature whatsoever upon any of\nthe assets of Buyer\x92s businesses.', u'\n', u'\xa0', u'\n', u'3.4\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Brokers\nand Finders', u'.\xa0 Buyer has not engaged\nor authorized any broker, finder, investment banker or other third party to act\non behalf of Buyer, directly or indirectly, as a broker, finder, investment\nbanker or in any other like capacity in connection with this Agreement or the\ntransactions contemplated hereby, or consented to or acquiesced in anyone so\nacting, and Buyer does not know of any claim for compensation from any such\nbroker, finder, investment banker or other third party for so acting on behalf\nof Buyer or of any basis for such a claim.', u'\n', u'\xa0', u'\n', u'8', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='8',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'ARTICLE 4', u'\n', u'\xa0', u'\n', u'CERTAIN OTHER COVENANTS\nAND AGREEMENTS', u'\n', u'\xa0', u'\n', u'4.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Consents and Filings', u' Each\nparty shall use all commercially reasonable efforts to obtain or make, as the\ncase may be, as soon as possible, all filings and requests for governmental\napprovals as may be required to be obtained or made by it in order to enable\nsuch party to perform its obligations under this Agreement.', u'\n', u'\xa0', u'\n', u'4.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Delivery of Books and Records', u'.\xa0 At the Closing, Seller will deliver to Buyer\nall original contracts, books and records of the Acquired Business.', u'\n', u'\xa0', u'\n', u'4.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Cooperation and Further Assurance', u'.\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 After the Closing, the parties\nshall cooperate in good faith to facilitate the transfer of the Stock in the\nmanner contemplated hereunder with minimum disruption for the parties. Each\nparty shall execute such further documents and instruments as the other may\nreasonably request to reflect the transactions contemplated hereunder and to\nvest in Buyer full title to the Stock and the Acquired Business.', u'\n', u'\xa0', u'\n', u'4.4\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Transfer Taxes', u'.\xa0 All sales, use, transfer, stamp, conveyance,\nor other similar taxes, duties, excises or governmental charges imposed by any\ngovernmental authority, domestic or foreign, with respect to the sale or\ntransfer of the Stock shall be borne entirely by Seller.', u'\n', u'\xa0', u'\n', u'4.5\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Transaction Expenses', u'.\xa0 Each party shall pay its own expenses\nincident to preparing for, entering into and carrying out this Agreement and\nthe transactions contemplated hereby, whether or not the Closing occurs.\xa0 Any such expenses of the Seller shall not be\ncharged to or incurred by the Acquired Business.', u'\n', u'\xa0', u'\n', u'4.6\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Non-compete', u'.\xa0 In consideration of the purchase price paid\nby Buyer hereunder and the other covenants and agreements contained herein,\nSeller hereby agrees, during the time in which any payment may be due and\npayable under either section 1.3 or section 1.4 of this Agreement and for a\nperiod of three (3) years thereafter, that neither Stockholder, Holdings nor\nany of its or her successors or assigns, shall compete, directly or indirectly,\nwith the Buyer, or any affiliate of the Buyer, in any business activity related\nto the Acquired Business within the countries of Denmark, Norway, Sweden or\nFinland.\xa0 For purposes of this section,\nSeller\x92s activity in disposing of existing inventory of Sports Enterprises\nshall not be considered to be activities in competition with Buyer or the\nAcquired Business.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'ARTICLE 5', u'\n', u'\xa0', u'\n', u'INDEMNIFICATION', u'\n', u'\xa0', u'\n', u'5.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Indemnity\nby the Seller', u'.\xa0 The Seller shall\nindemnify and hold harmless, Buyer and the officers, directors, agents,\naffiliates and representatives of Buyer or any of them (the \x93Buyer', u'\n', u'\xa0', u'\n', u'9', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='9',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'Indemnitees\x94) from and against, and shall reimburse the Buyer\nIndemnitees for any loss, liability, damage or expense, including reasonable\nattorneys\x92 fees and costs of investigation incurred as a result thereof, that\nthe Buyer Indemnitees shall incur or suffer (collectively \x93Buyer\x92s Recoverable\nLosses\x94), arising out of or resulting from (a) a breach or default by Seller of\nor under (i) any representation or warranty contained in ', u'Article 2', u'\nhereof; or (ii) any agreement or covenant under or pursuant to this Agreement;\nor (b) any liability or obligation of the Acquired Business arising or incurred\non or prior to the Effective Date and not disclosed to Buyer under this\nAgreement..', u'\n', u'\xa0', u'\n', u'5.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Indemnity\nby Buyer', u'.\xa0 Buyer shall indemnify and\nhold harmless the Seller and the officers, directors, agents, affiliates and\nrepresentatives of Seller or any of them (the \x93Seller Indemnitees\x94) from and\nagainst, and shall reimburse the Seller Indemnitees for any loss, liability,\ndamage or expense, including reasonable attorneys\x92 fees and cost of\ninvestigation incurred as a result thereof, that the Seller Indemnities shall\nincur or suffer (collectively, \x93Seller\x92s Recoverable Losses\x94) resulting from\n(a) a breach or default by Buyer of or under (i) any representation or warranty\ncontained in ', u'Article 3', u' hereof; or (ii) any agreement or covenant under\nor pursuant to this Agreement;\xa0 or (b)\nany liability or obligation of the Acquired Business arising or incurred after\nthe Effective Date or arising or incurred on or prior to the Effective Date and\ndisclosed to Buyer under this Agreement..', u'\n', u'\xa0', u'\n', u'5.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Limitations\non Liability; Offset', u'.\xa0 Seller shall\nhave no liability to Buyer under Section 5.1 above until the aggregate of the\nBuyer\x92s Recoverable Losses reaches $25,000, at which point Seller shall be\nliable for all of Buyer\x92s Recoverable Losses to the extent provided in Section\n5.1.\xa0 Seller shall not be obligated for\nBuyer\x92s Recoverable Losses under section 5.1(a) above to the extent such losses\nexceed the sum of $700,000 plus all amounts paid or payable under sections 1.3\nor 1.4 above, nor shall Seller be liable for any claims described in Section\n5.1(a) above which are first asserted after August 30, 2005, it being\nunderstood that claims made on or prior to such expiration date shall survive\nsuch expiration date\xa0 In the event that\nBuyer shall incur a loss that is a Buyer Recoverable Loss at a time in which\nany amounts remain to be paid under sections 1.3 or 1.4 above, Buyer may\nsatisfy Seller\x92s liability for such loss by reducing the amount of any such\npayment or payments under said sections in the amount of such loss.\xa0 If Seller disputes its or her liability for\nsuch loss, Seller may submit such dispute to the dispute resolution procedure\ndescribed below in section 5.4.', u'\n', u'\xa0', u'\n', u'5.4', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Claims\nfor Indemnification; Disputes', u'\n', u'\xa0', u'\n', u'(a)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Claims for Indemnification', u'.\xa0 Any party hereto shall give Seller or Buyer,\nas the case may be (the \x93Indemnitor\x94), written notice (the \x93Claim Notice\x94) of\nany claim (including the receipt of any demand) or the commencement of any\naction with respect to which indemnity may be sought (the \x93Claim\x94 or the\n\x93Claims).\xa0 The Claim Notice shall state\n(i)\xa0the aggregate amount of Buyer\x92s Recoverable Losses or Seller\x92s\nRecoverable Losses (in either case, \x93Recoverable Losses\x94) as to which indemnification\nis being sought (which amount may be estimated and updated from time to time),\n(ii)\xa0the components of the amount of Recoverable Losses for which\nindemnification is being sought (which components may be estimated and updated\nfrom time to time); and (iii)\xa0the specific grounds upon which the Claim\nfor indemnification is being made.\xa0 The\nright to indemnification for a Claim shall be deemed to be accepted by the\nIndemnitor unless, within 30 days after the Indemnitor\x92s receipt of the Claim', u'\n', u'\xa0', u'\n', u'10', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='10',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'Notice, the Indemnitor shall notify the claimant in writing that it\nobjects to the right to indemnification with respect to the Claim.', u'\n', u'\xa0', u'\n', u'(b)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Resolution\nof Disputes', u'.\xa0 The parties shall\nundertake in good faith to have their representatives promptly meet and attempt\nto resolve all disputes regarding indemnification.\xa0 If the parties are unable to resolve such disputes within 30\ndays, the resolution of the disputes shall be referred to and settled by\narbitration in accordance with the Rules of Procedure of the Danish Institute\nof Arbitration (Copenhagen Arbitration).\xa0\nThe arbitration tribunal shall be composed of three artibrators.\xa0 Each party shall appoint one arbitrator and\nthe Institute shall appoint a third arbitrator who shall be the chairman of the\narbitration tribunal.\xa0 If a party has\nnot appointed an arbitrator within 30 days of having requested or received\nnotice of the arbitration, the Institute shall appoint such arbitrator.\xa0 The arbitrators in such a proceeding shall\nhave the authority to resolve any such dispute and award judgments for monetary\namounts, but shall not have the authority to award damages in the nature of\npunitive, exemplary or consequential damages.\xa0\nThe arbitration shall be conducted in English.\xa0 Judgment upon the award may be entered in any court of competent\njurisdiction or application may be made to such court for a judicial acceptance\nof the award and an order of enforcement, as the case may be.\xa0 The successful or prevailing party shall be\nentitled to recover all attorneys\x92 fees, expert witness fees and other costs\nincurred in such action, in addition to any other relief to which it may be\nentitled.', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'ARTICLE 6', u'\n', u'\xa0', u'\n', u'GENERAL PROVISIONS', u'\n', u'\xa0', u'\n', u'6.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Entire\nAgreement; Modifications; Waiver', u'.\xa0\nSubject to the following sentence, this Agreement and the agreements\nancillary hereto, supersede any and all agreements heretofore made, written or\noral, relating to the subject matter hereof, and constitute the entire\nagreement of the parties relating to the subject matter hereof.\xa0 This Agreement supersedes the September 29,\n2003 option letter between Seller and Buyer except for the cost sharing\nprovisions of paragraph 1 of said letter, which provisions shall remain in\neffect until all such costs for the period specified therein have been\ncalculated and reimbursed by Buyer as provided in said paragraph 1. This\nAgreement may be amended only by an instrument in writing signed by Buyer and\nSeller.\xa0 Inspection of documents or the\nreceipt of information pursuant to this Agreement shall not constitute a waiver\nof any representation, warranty, covenant or condition hereunder.\xa0 No waiver shall be binding unless executed\nin writing by the party making such waiver.', u'\n', u'\xa0', u'\n', u'6.2\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Severability', u'.\xa0 If any clause or provision of this Agreement\nshall be held invalid or unenforceable by the final determination of a court of\ncompetent jurisdiction, and all appeals therefrom shall have failed or the time\nfor such appeals shall have expired, such clause or provision shall be deemed\neliminated from this Agreement but the remaining provisions shall nevertheless\nbe given full force and effect.', u'\n', u'\xa0', u'\n', u'6.3\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Successors\nand Assigns', u'.\xa0 Neither party hereto\nmay assign or transfer all or a portion of its rights or obligations under this\nAgreement without the prior written consent of the other party.', u'\n', u'\xa0', u'\n', u'11', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='11',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'Subject to the foregoing, this Agreement shall be binding upon and\ninure to the benefit of each of the parties hereto, and their respective\nsuccessors and assigns.', u'\n', u'\xa0', u'\n', u'6.4\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Counterparts', u'.\xa0 This Agreement may be executed in several\ncounterparts, each of which shall be deemed an original, and all of which\ntogether shall constitute one and the same instrument.', u'\n', u'\xa0', u'\n', u'6.5\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Governing\nLaw', u'.\xa0 This Agreement shall be\nconstrued and interpreted in accordance with the internal substantive laws of\nthe Country of Denmark.', u'\n', u'\xa0', u'\n', u'6.6\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Notices', u'.\xa0 All notices required or desired to be given\nhereunder shall be given in writing and signed by the party so giving notice,\nand shall be effective when personally delivered or sent by facsimile with\nreceipt confirmed or two business days after transmission if sent by overnight\ndelivery service and appropriate confirmation is received, addressed as set\nforth below.\xa0 Any party from time to\ntime may change such party\x92s address for giving notice by giving notice thereof\nin the manner outlined above:', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'If to Buyer:', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'dj Orthopedics, LLC', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'2985 Scott Street', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Vista, California\xa0\n  92083', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Attention:', u'\n', u'\n', u'\n', u'Donald M. Roberts', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Facsimile:', u'\n', u'\n', u'\n', u'(760) 734-3536', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'If to the Seller:', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'KD Holdings', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Attention:', u'\n', u'\n', u'\n', u'Kirsten Damgaard', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Facsimile:', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'6.7\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Recitals,\nSchedules and Exhibits', u'.\xa0 The\nrecitals, schedules and exhibits to this Agreement are incorporated herein and,\nby this reference, made a part hereof as if fully set forth at length herein.', u'\n', u'\xa0', u'\n', u'IN WITNESS WHEREOF, the parties hereto have executed\nthis Agreement as of the date first above written.', u'\n', u'\xa0', u'\n', u'12', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='12',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'DJ ORTHOPEDICS, LLC', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'By:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Name:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Title:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x93Buyer\x94', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'KD HOLDINGS', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'By:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Name:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Title:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Kirsten Damgaard', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\x93Seller\x94', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'13', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='13',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' ", u'\n', u'\n', u'\n', u'\n', u'EX-99.1\n', u'3\n', u'a04-10980_1ex99d1.htm\n', u'EX-99.1\n', u'\n', u'\n', u'Exhibit\n99.1', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Company Investor/ Media Contact:', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'dj Orthopedics, Inc.', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Mark Francois', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'Director of Investor\n  Relations', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'(760) 734-4766', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'www.djortho.com', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'FOR IMMEDIATE RELEASE', u'\n', u'\xa0', u'\n', u'DJ ORTHOPEDICS EXPANDS\nINTERNATIONAL STRATEGY WITH ACQUISITION', u'\nOF DISTRIBUTOR IN SCANDINAVIA', u'\n', u'\xa0', u'\n', u'SAN\nDIEGO, CA, September 28, 2004', u' \x96', u' ', u'dj Orthopedics, Inc.,\n(NYSE: DJO), a global medical device company specializing in rehabilitation and\nregeneration products for the non-operative orthopedic and spine markets, today\nannounced that it has acquired KD Innovation A/S, one of the Company\x92s third\nparty distributors in Scandinavia, to provide direct distribution of its\nproducts to the Nordic countries. The acquired company, renamed dj Orthopedics\nNordic ApS, is headquartered in H\xf8rsholm,\nnear Copenhagen, Denmark and, effective September 2004, has direct\nresponsibility for sales, marketing and distribution of dj Orthopedics\x92\nproducts in Denmark, Finland, Norway and Sweden.', u'\n', u'\xa0', u'\n', u'dj Orthopedics initiated its direct distribution strategy in major\ninternational markets in early 2002, forming subsidiaries in Germany, the\nUnited Kingdom and Canada, adding France in late 2003.\xa0 Currently, the Company sells its products,\nprimarily rigid knee braces and soft goods, in over 35 foreign countries\nincluding most European countries, Canada, Australia and Japan.\xa0 International net revenues comprised 12\npercent of total consolidated net revenues in the first six months of fiscal\n2004.', u'\n', u'\xa0', u'\n', u'\x93We have made significant progress with our international growth\nstrategy, building a portfolio of direct selling subsidiaries in key\ninternational markets. Direct presence in these markets provides us with better\naccess to our customer base and better control of our marketing programs, as\nwell as higher revenues and gross margins by capturing the in-market\ndistributor\x92s margin on sales of our products,\x94 said Les Cross, president and\nCEO of dj Orthopedics.\xa0 \x93With the\nacquisition of our strongest Scandanavian distributor, we now have the\nopportunity to broaden our reach throughout the Nordic region.\x94', u'\n', u'\xa0', u'\n', u'-more-', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'In three separate press\nreleases today, dj Orthopedics also announced that:', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The Company provided an update on its\nexpectations for the third quarter financial results and Regentek', u'TM', u'\nintegration.', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The\nCompany\x92s Board of Directors has authorized a $20 million stock repurchase\nprogram.', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The Company\x92s Mexico facility was named as\none of ', u'IndustryWeek\x92s', u' ten best\nmanufacturing plants in North America.\xa0\nThe release also updated the Company\x92s progress on its new manufacturing\nfacility in Mexico.\xa0 In the release dj\nOrthopedics announced that it will host an investor day at the new\nmanufacturing facility on November 30, 2004.', u'\n', u'\xa0', u'\n', u'Conference Call Information', u'\n', u'dj\nOrthopedics has scheduled an investor conference call to discuss today\x92s\nannouncements beginning at 10:00 AM, Pacific Time, 1:00 PM Eastern Time, today,\nSeptember 28, 2004.\xa0 Individuals\ninterested in listening to the conference call may do so by dialing (706)\n634-0177, using the reservation code 1133883.\xa0\nA telephone replay will be available for 48 hours following the\nconclusion of the call by dialing (706) 645-9291 and using the above\nreservation code.\xa0 The live conference\ncall also will be available via the Internet at www.djortho.com, and a\nrecording of the call will be available on the Company\x92s website.', u'\n', u'\xa0', u'\n', u'About dj Orthopedics, Inc.', u'\n', u'dj Orthopedics is a global medical device company\nspecializing in rehabilitation and regeneration products for the non-operative\northopedic and spine markets.\xa0 The\nCompany\x92s broad range of over 600 rehabilitation products, including rigid knee\nbraces, soft goods and pain management products, are used in the prevention of\ninjury, in the treatment of chronic conditions and for recovery after surgery\nor injury.\xa0 The Company\x92s regeneration\nproducts consist of bone growth stimulation devices that are used to treat\nnonunion fractures and as an adjunct therapy after spinal fusion surgery.', u'\n', u'\xa0', u'\n', u'The Company sells its products in the United States and in more than 35\nother countries through networks of agents, distributors and its direct sales\nforce that market its products to orthopedic and podiatric surgeons, spine\nsurgeons, orthopedic and prosthetic centers, third-party distributors,\nhospitals, surgery centers, physical therapists, athletic trainers and other\nhealthcare professionals.\xa0 For\nadditional information on the Company, please visit www.djortho.com', u'\n', u'\xa0', u'\n', u'Safe Harbor Statement', u'\n', u'This press release\ncontains forward-looking statements within the meaning of Section 27A of the\nSecurities Act of 1933 and Section 21E of the Securities Exchange Act of\n1934.\xa0 Such statements relate to, among\nother ', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'things, increases in\nrevenues and gross margins as a result of maintaining a direct presence in\ninternational markets including the Nordic countries as a result of the\nacquisition.\xa0 The words \x93believe,\x94\n\x93should,\x94 \x93expect,\x94 \x93intend,\x94 \x93estimate\x94 and \x93anticipate,\x94 variations of such\nwords and similar expressions identify forward-looking statements, but their\nabsence does not mean that a statement is not a forward-looking statement.\xa0 Forward-looking statements are based on the\nCompany\x92s current expectations and are subject to a number of risks,\nuncertainties and assumptions. The Company\xa0undertakes no obligation to update\nany forward-looking statements, whether as a result of new information, future\nevents or otherwise.\xa0 Among the important factors that could cause actual\nresults to differ significantly from those expressed or implied by such\nforward-looking statements are risks relating to the successful implementation\nof our international business strategy including our transition to direct\ndistribution of our products in select foreign countries; the continued growth\nof our markets; the success of our manufacturing initiatives; product\ndevelopment and/or product licensing and timely product introductions; our\ndependence on orthopedic professionals, agents and distributors for marketing\nour products; the restrictions imposed by the terms of our indebtedness;\ngovernment regulations; developing and protecting our intellectual property;\nand the effects of healthcare reform, managed care and buying groups on prices\nof our products.\xa0 Other risk factors are\ndetailed in our Annual Report on Form 10-K\nfor the 2003 calendar year, filed on March 12, 2004 with the Securities and\nExchange Commission.', u'\n', u'\xa0', u'\n', u'# # #', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\mramana\\04-10980-1\\task189510\\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' ", u'\n', u'\n', u'\n', u'\n', u'EX-99.2\n', u'4\n', u'a04-10980_1ex99d2.htm\n', u'EX-99.2\n', u'\n', u'\n', u'Exhibit 99.2', u'\n', u'\n', u'\n', u'\n', u'\n', u'Company\n  Investor/ Media Contact:', u'\n', u'\n', u'\n', u'\n', u'\n', u'dj Orthopedics, Inc.', u'\n', u'\n', u'\n', u'\n', u'\n', u'Mark Francois', u'\n  Director of Investor Relations', u'\n', u'\n', u'\n', u'\n', u'\n', u'(760) 734-4766', u'\n', u'\n', u'\n', u'\n', u'\n', u'mark.francois@djortho.com', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'FOR\nIMMEDIATE RELEASE', u'\n', u'\xa0', u'\n', u'DJ\nORTHOPEDICS PROVIDES UPDATE ON EXPECTATIONS FOR THIRD QUARTER FINANCIAL RESULTS\nAND REGENTEK INTEGRATION', u'\n', u'\x97', u'Conference Call and Live Webcast to be\nheld at 1:00 PM Eastern Time Today\x97', u'\n', u'\xa0', u'\n', u'SAN\nDIEGO, CA, September 28, 2004', u' \x97', u' ', u'dj\nOrthopedics, Inc., (NYSE: DJO), a global medical device company specializing in\nrehabilitation and regeneration products for the non-operative orthopedic and\nspine markets, today provided an update on the Company\x92s expected third quarter\nfinancial results and the integration of its Regentek', u' TM', u' division', u'.', u'\n', u'\xa0', u'\n', u'dj\nOrthopedics announced its Regentek integration strategy on July 27, 2004, with\nthe intention of driving stronger sales growth and profitability for the\nRegentek segment beginning in 2005.\xa0 dj\nOrthopedics announced today that the integration activities are progressing in\nline with the Company\x92s expectations.\xa0\nThe integration is comprised of the integration of the Regentek OL1000', u'TM', u'\nsales force into the Company\x92s DonJoy\xae sales channel, as well as the relocation\nof the Regentek business operations from Tempe, Arizona to dj Orthopedics\x92\nheadquarters in Vista, California.', u'\n', u'\xa0', u'\n', u'The Company announced today that it\nexpects to report third quarter revenue of approximately\xa0 $62.5 million, or approximately two percent\nbelow its original expected range of $63.5 million to $65.5 million. The Company\nalso confirmed that the short-term impact from the integration of the Regentek\nsales force on its third quarter Regentek OL1000 revenues was in line with its\nexpectations.\xa0 Additionally, although not\naffected by the integration, sales of the Regentek SpinaLogic\xae product fell\nshort of the Company\x92s expectations. As a result, the Company expects to report\ntotal Regentek revenues of about six percent less than pro forma revenues for\nthe third quarter of 2003.', u'\n', u'\xa0', u'\n', u'With respect to its core rehabilitation\nbusiness segments, DonJoy\xae, ProCare\xae, OfficeCare\xae and International, the\nCompany indicated that it enjoyed a strong quarter for athletic-related sales\nand sales of its osteoarthritic knee braces and, accordingly, expects to report\ngrowth for rigid knee bracing products of ', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\cmuller\\04-10980-1\\task189642\\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'approximately eight percent for the\nquarter. The Company also expects to report growth of approximately 18 percent\nin its International segment for the third quarter. However, the Company also\nexperienced an impact from recent changes in the California workers\x92 compensation\nsystem, which contributed to a decrease in third quarter revenue from customers\nin California of approximately $0.6 million, compared to the third quarter of\n2003. The Company also had lower than expected patient volume in its OfficeCare\nsegment, and expects growth in this segment to be less than one percent for the\nthird quarter.\xa0 In the aggregate, the\nCompany expects its rehabilitation revenues for the third quarter to be about\n$0.5 million less than original expectations.', u'\n', u'\xa0', u'\n', u'As a direct result of the lower Regentek\nrevenues, the Company anticipates reporting lower gross margins and operating\nmargins in the third quarter than those achieved in the second quarter of 2004.\nOperating margins are expected to be between 15 percent and 17 percent of net\nrevenues, before the impact of approximately $2 million of certain one-time\ncharges related to the Regentek integration. Excluding the impact of the\nintegration charges, which are expected to reduce reported earnings per share\nby approximately $0.05, the Company anticipates earnings per share for the\nthird quarter to be between $0.23 and $0.24. Reported earnings per share are\nexpected to be between $0.18 and $0.19. The Company expects operating cash flow\nfor the quarter to be over $10 million.', u'\n', u'\xa0', u'\n', u'\x93We remain confident that integrating the\nRegentek and DonJoy sales forces is the correct strategy for dj\nOrthopedics.\xa0 Greater sales depth across\nthe U.S. from one of the strongest distribution channels in non-operative\northopedics should enable us to grow faster than the market in 2005,\x94 said Les\nCross, president and CEO of dj Orthopedics.\xa0\n\x93Overall, the integration is proceeding according to plan.\xa0 Training of our DonJoy sales force is nearly\ncomplete and has been received with great enthusiasm.\xa0 Additionally, feedback from the field\nsuggests that the DonJoy channel is beginning to achieve success with new\nprescriptions, the result of leveraging our DonJoy relationships with many\northopedic surgeons that the separate Regentek sales force was unable to reach.\xa0 We have committed recruiting resources to\nassist our DonJoy distribution partners with the hiring of new Regentek\nspecialists, and we have already added several new specialists.\xa0 As expected, we have also experienced a\nmodest amount of turnover within the existing Regentek sales force and as\nanticipated, we have seen some disruption in Regentek OL1000 revenues during\nthe third quarter.\xa0 We remain confident\nthat this will be a short-term impact and that we will begin to see revenue\nupside from the integration during the fourth quarter and on into 2005. We\nbelieve that our SpinaLogic sales were impacted by unusually slow market\nconditions during the quarter. We are working closely with our selling partner,\nDePuy Spine, to better understand the current market trends in this segment and\nto optimize our selling strategy. We believe we have the best electrical bone\ngrowth stimulation technology in the industry and are ', u'\n', u'\xa0', u'\n', u'more', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\cmuller\\04-10980-1\\task189642\\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'well positioned to grow faster than our\ncompetitors and increase our share in both segments of this important market.\x94', u'\n', u'\xa0', u'\n', u'The relocation of the Regentek operations\nand administrative functions from Tempe, Arizona to dj Orthopedics\x92 Vista,\nCalifornia headquarters is expected to provide the Company with cost savings\nopportunities based on synergies in headcount and facilities.\xa0 This component of the integration is expected\nto save the Company approximately $3 million in net annual pre-tax operating\nexpenses, beginning in 2005. The Company indicated that this component of the\nintegration is proceeding on schedule to be completed before year end, and that\nit has successfully filled approximately 65 percent of the positions required\nto be added to its Vista location to support the Regentek business activities.\nThe Company previously announced that it expects to incur one-time charges\nrelated to the integration of $4 million to $5 million in the second half of\n2004.', u'\n', u'\xa0', u'\n', u'In conclusion, Mr. Cross said, \x93Although\nwe are disappointed by the slight revenue shortfall expected for the third\nquarter, we believe we have accomplished several important milestones in our\nbusiness thus far in 2004, including the introduction of several important new\nproducts, the expansion of our manufacturing facilities in Mexico, the\nrepayment of debt, reducing our annual interest expense by over $10 million,\nand perhaps most importantly, the soon to be completed integration of our\nRegentek business.\xa0 With the completion\nof the integration by the end of 2004 as planned, and with clear competitive\nproduct advantages, one of the largest and most productive distribution\nchannels in our industry and a world-class operations team driving continuous\nimprovement in our costs of operations and our customer service, we anticipate\na strong 2005, with significant earnings growth over 2004, demonstrating the\nquality and earnings potential of dj Orthopedics. We will provide updated\nexpectations for the fourth quarter of 2004 when we release our full third\nquarter earnings, but we are currently targeting a revenue range of $65 million\nto $68 million for the fourth quarter.\x94', u'\n', u'\xa0', u'\n', u'In three separate press releases today, dj Orthopedics also announced\nthat:', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The Company\x92s Board of\nDirectors has authorized a $20 million stock repurchase program.', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The Company\x92s Mexico\nfacility was named as one of ', u'IndustryWeek\x92s', u'\nten best manufacturing plants in North America.\xa0\nThe release also updated the Company\x92s progress on its new manufacturing\nfacility in Mexico.\xa0 In the release dj\nOrthopedics announced that it will host an investor day at the new\nmanufacturing facility on November 30, 2004.', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The Company has expanded its international\nstrategy with the acquisition of its largest distributor in Scandinavia.', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\cmuller\\04-10980-1\\task189642\\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' ", u'\n', u'\n', u'\xa0', u'\n', u'Conference Call Information', u'\n', u'dj Orthopedics has\nscheduled an investor conference call to discuss today\x92s announcements beginning\nat 10:00 AM, Pacific Time, 1:00 PM Eastern Time, today, September 28,\n2004.\xa0 Individuals interested in\nlistening to the conference call may do so by dialing (706) 634-0177, using the\nreservation code 1133883.\xa0 A telephone\nreplay will be available for 48 hours following the conclusion of the call by\ndialing (706) 645-9291 and using the above reservation code.\xa0 The live conference call also will be\navailable via the Internet at www.djortho.com, and a recording of the call will\nbe available on the Company\x92s website. ', u'dj Orthopedics intends to\nrelease full third quarter 2004 financial results on October 26, 2004.', u'\n', u'\xa0', u'\n', u'UBS Global Life Sciences Conference', u'\n', u'dj Orthopedics is scheduled to make a presentation to investors at the\nUBS Global Life Sciences Conference in New York City on September 30, 2004 at\n10:00 AM Eastern time.\xa0 Interested\ninvestors may listen to the presentation live via webcast by visiting the UBS\nwebsite at ', u'www.ibb.ubs.com', u' and clicking on the \x93Conferences\x94 box in the\nmiddle of the page, then follow the link for \x93Webcast\x94 under the Global Life\nSciences Conference heading.\xa0 The webcast\nwill be archived beginning three hours after the live event and continue until\nOctober 30, 2004.', u'\n', u'\xa0', u'\n', u'About\ndj Orthopedics, Inc.', u'\n', u'dj Orthopedics is a global medical device company\nspecializing in rehabilitation and regeneration products for the non-operative\northopedic and spine markets.\xa0 The\nCompany\x92s broad range of over 600 rehabilitation products, including rigid knee\nbraces, soft goods and pain management products, are used in the prevention of\ninjury, in the treatment of chronic conditions and for recovery after surgery\nor injury.\xa0 The Company\x92s regeneration\nproducts consist of bone growth stimulation devices that are used to treat\nnonunion fractures and as an adjunct therapy after spinal fusion surgery.', u'\n', u'The\nCompany sells its products in the United States and in more than 35 other\ncountries through networks of agents, distributors and its direct sales force\nthat market its products to orthopedic and podiatric surgeons, spine surgeons,\northopedic and prosthetic centers, third-party distributors, hospitals, surgery\ncenters, physical therapists, athletic trainers and other healthcare\nprofessionals.\xa0 For additional\ninformation on the Company, please visit www.djortho.com.', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\cmuller\\04-10980-1\\task189642\\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' ", u'\n', u'\n', u'Safe Harbor Statement', u'\n', u'This press release contains forward-looking statements within the\nmeaning of Section 27A of the Securities Act of 1933 and Section 21E of the\nSecurities Exchange Act of 1934.\xa0 Such\nstatements relate to, among other things, the Company\x92s future growth and\nprofitability, growth strategy, Regentek integration strategy and the Company\x92s\nanticipated financial results for the third and fourth quarters of 2004 and for\n2005.\xa0 The words \x93believe,\x94 \x93should,\x94 \x93expect,\x94\n\x93intend,\x94 \x93estimate\x94 and \x93anticipate,\x94 variations of such words and similar\nexpressions identify forward-looking statements, but their absence does not\nmean that a statement is not a forward-looking statement.\xa0 These forward-looking statements are based on\nthe Company\x92s current expectations and are subject to a number of risks,\nuncertainties and assumptions. The Company\xa0undertakes no obligation to\nupdate any forward-looking statements, whether as a result of new information,\nfuture events or otherwise.\xa0 Among the important factors that could cause\nactual results to differ significantly from those expressed or implied by such\nforward-looking statements are risks relating to the successful implementation\nof our business and integration strategy relative to our Regentek division; the\ncontinued growth of the bone growth stimulation market; the successful move of\nmanufacturing operations to our new Mexico facility; our ability to\nsuccessfully develop, license or acquire, and timely introduce and market new\nproducts or product enhancements; our dependence on orthopedic professionals,\nagents and distributors for marketing our products; our transition to direct\ndistribution of our products in select foreign countries; our international\noperations; the restrictions imposed by the terms of our indebtedness; our\nability to generate cash to service our indebtedness; government regulations;\ndeveloping and protecting our intellectual property; and the effects of\nhealthcare reform, managed care and buying groups on prices of our products.\xa0 Other risk factors are detailed in our Annual Report on Form 10-K for the 2003 calendar\nyear, filed on March 12, 2004 with the Securities and Exchange Commission.', u'\n', u'\xa0', u'\n', u'###', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\JMS\\cmuller\\04-10980-1\\task189642\\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' ", u'\n', u'\n', u'\n', u'\n', u'EX-99.3\n', u'5\n', u'a04-10980_1ex99d3.htm\n', u'EX-99.3\n', u'\n', u'\n', u'Exhibit\n99.3', u'\n', u'\n', u'\n', u'\n', u'\n', u'Company\n  Investor/ Media Contact:', u'\n', u'\n', u'\n', u'\n', u'\n', u'dj Orthopedics, Inc.', u'\n', u'\n', u'\n', u'\n', u'\n', u'Mark Francois', u'\n  Director of Investor Relations', u'\n', u'\n', u'\n', u'\n', u'\n', u'(760) 734-4766', u'\n', u'\n', u'\n', u'\n', u'\n', u'mark.francois@djortho.com', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'FOR IMMEDIATE RELEASE ', u'\n', u'\xa0', u'\n', u'DJ ORTHOPEDICS\x92 BOARD OF DIRECTORS AUTHORIZES STOCK\nREPURCHASE PROGRAM', u'\n', u'\xa0', u'\n', u'SAN\nDIEGO, CA, September 28, 2004 ', u'\x96 dj Orthopedics, Inc. (NYSE: DJO), a global medical\ndevice company specializing in rehabilitation and regeneration products for the\nnon-operative orthopedic and spine markets, ', u'announced\ntoday that its board of directors has authorized a program to repurchase up to\n$20 million of dj Orthopedics\x92 common stock.\xa0\nThe shares may be repurchased at times and prices as determined by\nmanagement and may be completed through open market or privately negotiated\ntransactions.\xa0 The repurchases will be\nmade in accordance with applicable state and federal law and in accordance with\nthe terms and subject to the restrictions of Rule 10b-18 under the Securities\nExchange Act of 1934, as amended.\xa0 Shares\nwill be retired and cancelled upon repurchase.\xa0\nAs of September 27, 2004, dj Orthopedics had approximately 22.1 million\nshares outstanding.', u'\n', u'\xa0', u'\n', u'\x93', u'The first half of 2004 was marked by the\nachievement of many important milestones in revenue growth, operating results\nand continued strong cash flow,\x94 said Les Cross, president and CEO of dj\nOrthopedics.\xa0 \x93With a conviction that dj\nOrthopedics will continue to generate strong free cash flow, in concert with a\ncurrent share price that is trading well below its recent highs and a low\ninterest rate environment, a share repurchase program represents a sound and\naccretive use of cash.\x94', u'\n', u'\xa0', u'\n', u'dj Orthopedics said that it\nis in the process of obtaining an amendment to its credit agreement which is\nrequired prior to implementing the stock repurchase program.', u'\n', u'\xa0', u'\n', u'In three separate press releases today, dj Orthopedics also announced\nthat:', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The\nCompany provided an update on its expectations for the third quarter financial\nresults and Regentek integration.', u'\n', u'\x95', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'The\nCompany\x92s Mexico facility was named as one of ', u'IndustryWeek\x92s', u'\nten best manufacturing plants in North America.\xa0 The release also updated the Company\x92s progress on its new\nmanufacturing facility in ', u'\n', u'-more-', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\vgurram\\04-10980-1\\task189513\\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Mexico.\xa0 In the release dj\n  Orthopedics announced that it will host an investor day at the new\n  manufacturing facility on November 30, 2004.', u'\n', u'\n', u'\n', u'\n', u'\n', u'\x95', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'The ', u'Company has expanded its\n  international strategy with the acquisition of its largest distributor in\n  Scandinavia.', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'Conference Call Information', u'\n', u'\xa0', u'\n', u'dj Orthopedics has scheduled an investor conference\ncall to discuss today\x92s announcements beginning at 10:00 AM, Pacific Time, 1:00\nPM Eastern Time, today, September 28, 2004.\xa0\nIndividuals interested in listening to the conference call may do so by\ndialing (706) 634-0177, using the reservation code 1133883.\xa0 A telephone replay will be available for 48\nhours following the conclusion of the call by dialing (706) 645-9291 and using\nthe above reservation code.\xa0 The live\nconference call also will be available via the Internet at www.djortho.com, and\na recording of the call will be available on the Company\x92s website.', u'\n', u'\xa0', u'\n', u'About dj Orthopedics, Inc.', u'\n', u'\xa0', u'\n', u'dj Orthopedics is a global medical device company\nspecializing in rehabilitation and regeneration products for the non-operative\northopedic and spine markets.\xa0 The\nCompany\x92s broad range of over 600 rehabilitation products, including rigid knee\nbraces, soft goods and pain management products are used in the prevention of\ninjury, in the treatment of chronic conditions and for recovery after surgery\nor injury.\xa0 The Company\x92s regeneration\nproducts consist of bone growth stimulation devices that are used to treat\nnonunion fractures and as an adjunct therapy after spinal fusion surgery.', u'\n', u'\xa0', u'\n', u'The Company sells its products in the United States and in more than 35\nother countries through networks of agents, distributors and its direct sales\nforce that market its products to orthopedic and podiatric surgeons, spine\nsurgeons, orthopedic and prosthetic centers, third party distributors,\nhospitals, surgery centers, physical therapists, athletic trainers and other healthcare\nprofessionals.\xa0 For additional\ninformation on the Company, please visit www.djortho.com.', u'\n', u'\xa0', u'\n', u'Safe Harbor Statement', u'\n', u'\xa0', u'\n', u'This press release contains forward-looking statements within the\nmeaning of Section 27A of the Securities Act of 1933 and Section 21E of the\nSecurities Exchange Act of 1934.\xa0 Such\nstatements relate to, among other things, the Company\x92s anticipated repurchase\nof its common stock and the anticipated effect this may have on the Company\x92s\nearnings and the Company\x92s future cash flow.\xa0\nThe words \x93believe,\x94 \x93should,\x94 \x93expect,\x94 \x93intend,\x94 \x93estimate\x94 and\n\x93anticipate,\x94 variations of such words and similar expressions identify\nforward-', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\vgurram\\04-10980-1\\task189513\\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' ", u'\n', u'\n', u'\n', u'\xa0', u'\n', u'looking statements, but their absence does not mean that a statement is\nnot a forward-looking statement.\xa0 Forward-looking\nstatements are based on the Company\x92s current expectations and are subject to a\nnumber of risks, uncertainties and assumptions. The Company\xa0undertakes no\nobligation to update any forward-looking statements, whether as a result of new\ninformation, future events or otherwise.\xa0 Among the important factors that\ncould cause actual results to differ significantly from those expressed or\nimplied by such forward-looking statements are risks relating to the successful\nimplementation of our business strategy; the continued growth of our markets;\nthe success of our manufacturing initiatives; product development and/or\nproduct licensing and timely product introductions; our dependence on\northopedic professionals, agents and distributors for marketing our products;\nour transition to direct distribution of our products in select foreign\ncountries; our international operations; the restrictions imposed by the terms\nof our indebtedness; government regulations; developing and protecting our\nintellectual property; and the effects of healthcare reform, managed care and\nbuying groups on prices of our products.\xa0\nOther risk factors are detailed in our Annual Report on Form 10-K for the 2003 calendar year, filed on March 12,\n2004 with the Securities and Exchange Commission.', u'\n', u'\xa0', u'\n', u'# # #', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u" SEQ.=1,FOLIO='',FILE='C:\\jms\\vgurram\\04-10980-1\\task189513\\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' ", u'\n', u'\n', u'\n', u'\n', u'GRAPHIC\n', u'6\n', u'g109801mmimage002.jpg\n', u'GRAPHIC\n', u'\nbegin 644 g109801mmimage002.jpg\nM_]C_X``02D9)1@`!`0$`8`!@``#__@`\nM&LD.@803H2#Q)T\\%-+K&0\'K?2#C8>;:M=\\SO$ZCZ*7RN)9E?5O26)HA7E$FD\nM3M-_3X%""014=M3D;T>U.29\'=L,8VR\\!K97``:^*BO:N1[_:\\YWU53M-COPN\nM64XJ7/WV/0R+SS[5R/?[7G.^JY,R64D>UC+MMSW$!K6RN))[!Q48NQET.7Y_\nMH]"(J.P0N9#:"\'%W\\AD8#(\\QD,>=YKNP@GA\\5HWLA', u'=*]B_T7GGVKD>_P!KSG?52&`R5]^T6,8^]8', u'_*,>R0QUJS\'E@=IS(0AGS9NG\nM%\'MAF\'0%YAK,;`S?>7%NO$C4_-I6:!LD?2$Z&&S.^-M,R3-?(7`DGAPY#FWD\nML>PMJ*PW(3/D:+5JT^1T6O6:WAS\'BXK-L_\\`O6U>>NGDQ[(&G^W@?^0A"*MV\nMK!=M;DP`23:>`!XK:CV9KLR,.(MY!T.3G``C;%O1Q.[774\\.0.FJY9.\nMQ#4Z1IK-@:PQ9$/DX:]4/U*D35-/;6SG\\B]HQ\\5A]F*4/!]/Q)8UG:>7AIQ6\nMM3,]L[24;.*3I]-?5Z(AL/LV[*6+]22R*UJG$]Y8YFK>H=#O.UZO$_-2^`P6\nM(&T>)=7S3;).DY8(=""S5Q#N/5_#KQ6C1R(]D[29%\\C&6;I;&UF]Q(>\\N?H.\nMS0?[7\'8IA=D+YC(]8;CIO0-)`WGD``#7Y$HJ9"V=JX6C', u"MB.P()FF$L`CN(1/8=_(.DEZX!&\nMC0UHTUU/,E-`N:-K6+RK&/KE7^Z&HW#5:E2K8R]R2L;C=^&**$2.#.6^[4C0\nM=G,E9JN+FPVW5+'SN:Y\\5V'1S>3@7-((\\00I3/4#GLU4OPR1LQ3J\\0=8+P&P\nMM:.LT]CAQX", u'B^\nM2ZD1%LGBPB(@"UACZ0M&T*TG3FH+8:-QPDMQXT=', u"_>C)E:'?B:#K\nMIQ[=%/5:T5.K%6@9N11-#6CL`0@KC.=&^8R6;N7H;-)LQ4GNISO>J'F/^U/=3G>]4/,?]JMM$PXCJ_%>5[%2>ZG.]ZH>8_[5\nMMXKHTS5'+TKDMFD8Z]B.1P:]^I#7`G3J_)6@B8\n", u'\n', u'\n', u'GRAPHIC\n', u'7\n', u'g109801moimage002.gif\n', u'GRAPHIC\n', u'\nbegin 644 g109801moimage002.gif\nM1TE&.#EA;P`S`\'*T(/B%X.:T8\'!`%]$*L1JQ"MK*ZPK[*UL;>T\nMN+.[M80/!`P"7@=U1G4#0J[*JQJNS', u"`@RXH\\29P6G8$!Z$L(&0BX3:\nM%$+CYF)$GRXFU%Q,\\BY6.X^YWO%J)R1>K8\\B(3@L$R+-2B36LE53-C.;LHK1\nM:DY31K',!?]43.#=$VJOJ#L)+CZ\\", u'6"X4$$`G`-T";8:@0M7"\'$B3@%.VHA?/@PL.\nM@1._>VF%`IT,0Q@(HA#Y0', u'YBS@#58,6N^L3"10H$\nMSR8(N3TD@@IZ)E*,>)8;P503;"&0&!*"K>DIIP(8`*\nM`BD\\Y,H&0J"3VRJ4T;:*62XTB`"*39\'\'`@*NA"`B3U=H14!K1!10P`+&`$.$\nM2(8A-M0\'+GA`BV&ZN0B!:/8P&>4]S=%"#SY)0L6%&O6YALI&0HS@DIKGK!@+\nM/0VV`M8N^;DR*00"OFC=+?1P$`N%4=1EA\'/0#7&!($4LTX$+*$2$0\'75X&30\nM@JW>Q)^=)3YCF%(ASO+6%6IP"(H:1HA1:*7H[.K.I4V"%&`Z"SK9WXX1K.H!\nM5`/N', u'I\'T46`TW\\FOL-DLJL8]HRD\'^"F6W\\0+G:%A1^ZX%@==U`V\nMA$"([IB6@OLM0XAT$*SZ70JKK!>1P2:H0)M9*$1@%LO1"!J%`X3&)X(!/0\\Q\nM`BJ,$?7)"D]I\\-0J)7KZBM+N?)""/=0MON^RGX_0*P[\\0/X=@`A)2`:O\',$[&`70$`\n>8$!?S5=?T0,5]&[]]MQW[_WWX(', u'\n', u'\n', u'\n', u'GRAPHIC\n', u'8\n', u'g109801noimage002.jpg\n', u'GRAPHIC\n', u'\nbegin 644 g109801noimage002.jpg\nM_]C_X``02D9)1@`!`0$`8`!@``#__@`A:5MMH;90M)R",9.#X5FO$.URH5SN\\=3;TE,)QDN(', u'4>7DZ+YU&[0UYQ63E$%03KIUB,@9VD', u'K@E+TN:2M2UC.HC.`D9W"KNXPQG2)BQ_N5-M2T\nM\\TVIM,M3HY/&W!`&W-"\'B9-"8[3MHFOEI(;ERG"$`8&KN`QPWU`M;:%:/:3R\nMVD)0V^M\\(2D8`"4G&!XU:V-$NS:)K1,BB,J*RM7\\P**CM).S=42UQS\'_`&:O\nM9\'Q.Q\'G%?W`G_6*AX&', u"NH]EN;$.//@RPYS:>R&UK:`*FR#E*L\nM'>,[Q7V=", u';\\_"9T8L\\%J`I"WF5R4?\nM;D\\F5*QG=\\60GPJGOUR;NURYPRVMME#+;3:%XR`E(\'5XU-N=VM', u'2C4`*V]MM^ZXGY"/TBK)>+/,TLH\nME*EWL:OQD2J***M.?"O#J^2:6X4E6JDG"1DG\'"O=%`*EVOK%ZT6Y.!ME7`\\B\nMA@D:Z3G"L@;L`&F!NWLIM2+', u'\n', u'\n', u'\n-----END PRIVACY-ENHANCED MESSAGE-----\n']